Plasma from patients exposed to ischemia reperfusion contains clastogenic factors and stimulates the chemiluminescence response of normal leukocytes.
Clastogenic factors (CFs) are released by cells exposed to superoxide radicals and are found in various situations of oxidative stress. Certain of their components stimulate further superoxide production by competent cells, as shown with cytochrome c assay in previous work. In the present study, we report CF formation after ischemia reperfusion in patients undergoing coronary bypass surgery. Plasma ultrafiltrates, collected 20 min after reperfusion, had clastogenic properties in contrast to those collected before ischemia. We also show that the luminol-enhanced chemiluminescence response of neutrophils from healthy persons is increased when these cells are exposed to CF-containing postreperfusion samples from patients. Light emission was reduced to control values in the presence of superoxide dismutase. The burst of oxyradicals upon reperfusion is probably the initiating event of CF formation, which in turn leads to further oxyradical generation. This amplification process may explain why detectable levels of CF need a delay of at least 10 min. The activated state of neutrophils in ischemia reperfusion is at once a consequence and a source of CFs. Individual variation in the persistence of this clastogenic and leukocyte-activating material was observed. Therefore, antioxidants for prevention of ischemia reperfusion injury should be continued during the postoperative course.
Emerit
I
I
Free Radical Research Group, Université Paris VI, France.
Fabiani
J N
JN
Levy
A
A
Ponzio
O
O
Conti
M
M
Brasme
B
B
Bienvenu
P
P
Hatmi
M
M
D000975:Antioxidants / Q000627:therapeutic use; D002851:Chromatography, High Pressure Liquid; D001026:Coronary Artery Bypass; D006801:Humans; D007292:Inosine Nucleotides / Q000378:metabolism; D007700:Kinetics; D008163:Luminescent Measurements; D008165:Luminol / Q000494:pharmacology; D009153:Mutagens / Q000032:analysis*; D015425:Myocardial Reperfusion; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control; D009504:Neutrophils / Q000502:physiology*; D013482:Superoxide Dismutase / Q000494:pharmacology; D013481:Superoxides / Q000097:blood
D000975:Antioxidants; D007292:Inosine Nucleotides; D009153:Mutagens; D013481:Superoxides; D008165:Luminol; D013482:Superoxide Dismutase